This case involves a scenario in which a pharmaceutical company, in the planning of its annual meeting of shareholders, the possibility of the destruction of the activist. "Hide
on Idalene F. Kesner Source: Business Horizons 3 pages. Publication Date: November 15, 2012. Prod. #: BH495-PDF-ENG
Related Case Solutions & Analyses:
Note on the Nonprofit Coherence Framework
Centre Partners–American Seafoods 2003
Developing Leaders
Group Process in the Challenger Launch Decision (A)
SAS Institute (B): The Decision to Go Public
Sula Vineyards
Pulmocit: Negotiating Pharmaceutical Products with the Government (B) – Dr Rozentale (Alpenian Government) – Confidential Instructions
Project Deutschland: Unpeeling the Onion of a Distressed Real Estate Portfolio
Csr In Sub Saharan Africa
Task Rabbit
